These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


260 related items for PubMed ID: 16892151

  • 1. [Effect of topical tacrolimus ointment on expression of Toll-like receptors 2 and 4 in lesional atopic dermatitis skin].
    Xie ZQ, Liu LL, Yang GY, Zhu XJ.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Aug 18; 38(4):420-3. PubMed ID: 16892151
    [Abstract] [Full Text] [Related]

  • 2. [Expression of nuclear factor kappaB and the effect of topical tacrolimus ointment on lesional atopic dermatitis skin].
    Xie ZQ, Liu LL, Dou X, Wen WJ, Wang D, Zhu XJ.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Oct 18; 36(5):487-90. PubMed ID: 15489928
    [Abstract] [Full Text] [Related]

  • 3. TLR2 and TLR4 expression in atopic dermatitis, contact dermatitis and psoriasis.
    Panzer R, Blobel C, Fölster-Holst R, Proksch E.
    Exp Dermatol; 2014 May 18; 23(5):364-6. PubMed ID: 24661005
    [Abstract] [Full Text] [Related]

  • 4. Budesonide, but not tacrolimus, affects the immune functions of normal human keratinocytes.
    Kis K, Bodai L, Polyanka H, Eder K, Pivarcsi A, Duda E, Soos G, Bata-Csorgo Z, Kemeny L.
    Int Immunopharmacol; 2006 Mar 18; 6(3):358-68. PubMed ID: 16428071
    [Abstract] [Full Text] [Related]

  • 5. Tacrolimus ointment for the treatment of atopic dermatitis: clinical and pharmacologic effects.
    Rico MJ, Lawrence I.
    Allergy Asthma Proc; 2002 Mar 18; 23(3):191-7. PubMed ID: 12125507
    [Abstract] [Full Text] [Related]

  • 6. Normal keratinocytes express Toll-like receptors (TLRs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasis.
    Baker BS, Ovigne JM, Powles AV, Corcoran S, Fry L.
    Br J Dermatol; 2003 Apr 18; 148(4):670-9. PubMed ID: 12752123
    [Abstract] [Full Text] [Related]

  • 7. Expression of TLR2 and TLR4 on peripheral blood monocytes during exacerbation of atopic dermatitis.
    Tsybikov NN, Petrisheva I, Fefelova EV, Kuznik BI, Magen E.
    Allergy Asthma Proc; 2015 Apr 18; 36(6):e140-5. PubMed ID: 26534745
    [Abstract] [Full Text] [Related]

  • 8. Effects of tacrolimus ointment on Toll-like receptors in atopic dermatitis.
    Antiga E, Volpi W, Torchia D, Fabbri P, Caproni M.
    Clin Exp Dermatol; 2011 Apr 18; 36(3):235-41. PubMed ID: 21070333
    [Abstract] [Full Text] [Related]

  • 9. Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Undre NA, Moloney FJ, Ahmadi S, Stevenson P, Murphy GM.
    Br J Dermatol; 2009 Mar 18; 160(3):665-9. PubMed ID: 19076975
    [Abstract] [Full Text] [Related]

  • 10. Anti-inflammatory effects of lithium gluconate on keratinocytes: a possible explanation for efficiency in seborrhoeic dermatitis.
    Ballanger F, Tenaud I, Volteau C, Khammari A, Dréno B.
    Arch Dermatol Res; 2008 Jun 18; 300(5):215-23. PubMed ID: 18330588
    [Abstract] [Full Text] [Related]

  • 11. Effects of tacrolimus ointment on the expression of substance P, nerve growth factor, and neurotrophin-3 in atopic dermatitis.
    Kim HO, Lee CH, Ahn HK, Park CW.
    Int J Dermatol; 2009 Apr 18; 48(4):431-8. PubMed ID: 19335435
    [Abstract] [Full Text] [Related]

  • 12. Tacrolimus ointment causes inflammatory dendritic epidermal cell depletion but no Langerhans cell apoptosis in patients with atopic dermatitis.
    Schuller E, Oppel T, Bornhövd E, Wetzel S, Wollenberg A.
    J Allergy Clin Immunol; 2004 Jul 18; 114(1):137-43. PubMed ID: 15241357
    [Abstract] [Full Text] [Related]

  • 13. Comparison of effects of tacrolimus ointment and mometasone furoate cream on the epidermal barrier of patients with atopic dermatitis.
    Dähnhardt-Pfeiffer S, Dähnhardt D, Buchner M, Walter K, Proksch E, Fölster-Holst R.
    J Dtsch Dermatol Ges; 2013 May 18; 11(5):437-43. PubMed ID: 23551950
    [Abstract] [Full Text] [Related]

  • 14. Topical Tacrolimus versus Hydrocortisone on Atopic Dermatitis in Paediatric Patients: A Randomized Controlled Trial.
    Rahman MF, Nandi AK, Kabir S, Kamal M, Basher MS, Banu LA.
    Mymensingh Med J; 2015 Jul 18; 24(3):457-63. PubMed ID: 26329939
    [Abstract] [Full Text] [Related]

  • 15. Tacrolimus ointment (Protopic) for atopic dermatitis.
    Pascual JC, Fleisher AB.
    Skin Therapy Lett; 2004 Nov 18; 9(9):1-5. PubMed ID: 15550992
    [Abstract] [Full Text] [Related]

  • 16. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
    Kubota Y, Yoneda K, Nakai K, Katsuura J, Moriue T, Matsuoka Y, Miyamoto I, Ohya Y.
    J Am Acad Dermatol; 2009 Feb 18; 60(2):212-7. PubMed ID: 19027990
    [Abstract] [Full Text] [Related]

  • 17. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
    Schachner LA, Lamerson C, Sheehan MP, Boguniewicz M, Mosser J, Raimer S, Shull T, Jaracz E, US Tacrolimus Ointment Study Group.
    Pediatrics; 2005 Sep 18; 116(3):e334-42. PubMed ID: 16140675
    [Abstract] [Full Text] [Related]

  • 18. Topically applied semaphorin 3A ointment inhibits scratching behavior and improves skin inflammation in NC/Nga mice with atopic dermatitis.
    Negi O, Tominaga M, Tengara S, Kamo A, Taneda K, Suga Y, Ogawa H, Takamori K.
    J Dermatol Sci; 2012 Apr 18; 66(1):37-43. PubMed ID: 22381253
    [Abstract] [Full Text] [Related]

  • 19. Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis.
    Wollenberg A, Sharma S, von Bubnoff D, Geiger E, Haberstok J, Bieber T.
    J Allergy Clin Immunol; 2001 Mar 18; 107(3):519-25. PubMed ID: 11240954
    [Abstract] [Full Text] [Related]

  • 20. Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis.
    Park CW, Lee BH, Han HJ, Lee CH, Ahn HK.
    Br J Dermatol; 2005 Jun 18; 152(6):1173-81. PubMed ID: 15948978
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.